Evidence mapPaperPMID 40964902Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Sex and Gender Dimensions in Hazard and Risk Assessment of Engineered Nanomaterials.

Lucija Božičević, Karolina Jagiello, Anita Sosnowska, Maciej Stepnik, Maria Dusinska, Iseult Lynch, Nikolina Peranić, Ivona Capjak, Valérie Fessard, Mihaela R Cimpan and 4 more

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lucija BožičevićInstitute for Medical Research and Occupational Health, Zagreb, Croatia.ORCID https://orcid.org/0000-0001-5222-7678
Karolina JagielloQSAR Lab, Gdansk, Poland.ORCID https://orcid.org/0000-0002-2730-6873
Anita SosnowskaQSAR Lab, Gdansk, Poland.ORCID https://orcid.org/0000-0003-3288-4309
Maciej StepnikQSAR Lab, Gdansk, Poland.ORCID https://orcid.org/0000-0003-1586-2482
Maria DusinskaDepartment of Environmental Chemistry and Health Effects, The Environment and Climate Research Institute NILU, Health Effects Laboratory, Kjeller, Norway.ORCID https://orcid.org/0000-0003-1358-1652
Iseult LynchSchool of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0003-4250-4584
Nikolina PeranićInstitute for Medical Research and Occupational Health, Zagreb, Croatia.ORCID https://orcid.org/0000-0002-9305-4096
Ivona CapjakInstitute for Medical Research and Occupational Health, Zagreb, Croatia.ORCID https://orcid.org/0000-0002-4652-4155
Valérie FessardFougères Laboratory, Toxicology of Contaminants Unit, ANSES, French Agency for Food, Environmental and Occupational Health & Safety, Fougères, France.ORCID https://orcid.org/0000-0001-9046-9117
Mihaela R CimpanDepartment of Clinical Dentistry, Faculty of Medicine, University of Bergen, Bergen, Norway.ORCID https://orcid.org/0000-0003-2029-3173
Arno C GutlebInstitute for Medical Research and Occupational Health, Zagreb, Croatia.ORCID https://orcid.org/0000-0001-9725-9112
Elise Runden PranDepartment of Environmental Chemistry and Health Effects, The Environment and Climate Research Institute NILU, Health Effects Laboratory, Kjeller, Norway.ORCID https://orcid.org/0000-0002-5541-4513
Tomasz PuzynQSAR Lab, Gdansk, Poland.ORCID https://orcid.org/0000-0003-0449-8339
Ivana Vinković VrčekInstitute for Medical Research and Occupational Health, Zagreb, Croatia.ORCID https://orcid.org/0000-0003-1382-5581

Funding

European Regional Development Fund KK.01.1.1.02.0007Horizon 2020 Framework Programme 8144259HORIZON EUROPE Framework Programme PARC 101057014NextGenerationEU 533-03-23-0006UKRI Innovate UK Horizon Guarantee Fund 10045979
6 · The paper itself

Abstract

The knowledge on hazards and risks connected to human exposure to engineered nanomaterials (ENMs) is still very limited, despite several decades of research and regulatory efforts at the international level. In particular, sex/gender-related responses to such exposure have not been clearly articulated so far in any of the existing guidance documents or regulatory relevant opinions provided to the parties involved in the risk assessment and risk management of ENMs. We aimed to demonstrate the relevance of the sex/gender dimension for the characterization of the risks and hazards associated with ENMs by analyzing existing scientific data on sex-related differences in response to ENMs exposure. This was achieved by performing an extensive review of in vivo mammalian toxicity studies published in PubMed and Web of Science databases. Further analysis was performed only for data reported in publications that satisfied scientific quality criteria assessed using the GUIDEnano approach. Finally, we demonstrated the importance of the sex/gender dimension for safety testing of ENMs in the future and provided recommendations on how to include the sex/gender dimension in toxicity testing of ENMs to ensure precise, transparent, and reliable conclusions in the process of hazard and risk assessments. This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine.

Indexed as

NanostructuresSex CharacteristicsAnimalsFemaleHumansMaleRisk AssessmentSex Factors

Identifiers

PMID40964902
PMCPMC12444842

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.